In HGSC patients, shallow whole genome sequencing (sWGS) of circulating tumor DNA (ctDNA) from plasma revealed a 16% increase in chromosome 12p13.33 amplification (location of FOXM1) after the acquisition of chemotherapy resistance [128]. Here, FOXM1 is linked to neoplasm.